Title:
【発明の名称】ソマトスタチンの作動因子及び拮抗因子
Document Type and Number:
Japanese Patent JP2001525793
Kind Code:
A
Abstract:
The present invention relates to somatostatin ligands (Ia) or (Ib) which are useful for treating medical disorders related to binding to human somatostatin receptor subtypes, wherein X is =S, =O, =NH, =NCOPh or =N(CN), A is aryl optionally substituted with halogen, amino, hydroxy, nitro, C1-6-alkyl, C1-6-alkoxy or aryl, B is aryl optionally substituted with halogen, amino, hydroxy, C1-6-alkyl, C1-6-alkoxy or aryl, D is aryl, amino, optionally substituted with halogen, amino, hydroxy, C1-6-alkyl, C1-6-alkoxy or aryl, or a pharmaceutically acceptable salt thereof.
Inventors:
Ankersen, Michael
Steedsen, Kirsten Engirl
Henrik Sunne, Anselsen
Steedsen, Kirsten Engirl
Henrik Sunne, Anselsen
Application Number:
JP54040897A
Publication Date:
December 11, 2001
Filing Date:
May 14, 1997
Export Citation:
Assignee:
Novo Nordisk Actiesel Scab
International Classes:
C07D215/38; A61K31/44; A61K31/4439; A61K31/444; A61K31/47; A61K31/4709; A61K31/506; A61K31/5377; A61P1/04; A61P5/02; A61P9/00; A61P35/00; A61P43/00; C07D213/74; C07D213/75; C07D401/12; (IPC1-7): C07D401/12; A61K31/44; A61K31/4439; A61K31/444; A61K31/47; A61K31/4709; A61K31/5377; A61P1/04; A61P5/02; A61P9/00; A61P35/00; A61P43/00; C07D213/75; C07D215/38
Attorney, Agent or Firm:
Takashi Ishida (4 others)